AIDS Healthcare Foundation Selects the Inovalon ONE® Platform
World’s Largest Provider of HIV/AIDS Medical Care Will Implement ScriptMed® Cloud to Improve Clinical Outcomes for PatientsBOWIE, Md., Feb. 08,...
Year: 2021
Paratek Announces Expansion of NUZYRA® Launch into the Community Setting
Building on the successful hospital-focused launch of NUZYRA, Paratek is expanding commercial promotion of NUZYRA into the community setting aimed...
VitalHub Announces Licensing Deal with Surrey and Sussex Healthcare NHS Trust
TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a...
Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs
Dr. Dugar Brings Over 20 Years of Experience in Medical Affairs, Clinical and Commercial Development, and Real-World Evidence, Including in...
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at...
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, Feb. 08, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and...
GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels
New Analysis Published in Psychiatry Research SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a...
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
Conference Call and Webcast To be Held Thursday, February 11, 2021 4:30 pm Eastern TimeNEW YORK, Feb. 08, 2021 (GLOBE...
IN8bio Appoints Patrick McCall as Chief Financial Officer
NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous...
Annexon Welcomes William H. Carson, M.D. to the Board of Directors
Thomas G. Wiggans appointed ChairmanSOUTH SAN FRANCISCO, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical...
Tonix Pharmaceuticals to Develop COVID-19 Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Pre-IND Meeting Written Response from FDA Provides Guidance on Product Development and Clinical Testing Protocol Intradermal Test is Designed to...
XORTX Announces Over Subscribed Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 08, 2021 (GLOBE...
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options
- Phase 1/2 trial expected to commence in first half of 2021 - Company has three INDs cleared for rare...
OliX Pharmaceuticals Launches New Subsidiary to Develop mRNA Vaccines and Therapeutics
SUWON, Republic of Korea, Feb. 08, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi...
China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility)
SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
Orion and Bayer expand development program for darolutamide in prostate cancer
ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET Orion and Bayer expand development program for darolutamide in...
Progressive Care Announces Record December and Full Year 2020 Performance Data
MIAMI, FL, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
Targeting initiation of dose confirmation trial by end of 2021 with data readout by end of 2022 Initiation of Phase 3...
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical...
HEXO Corp appoints General Manager of US operations
OTTAWA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today that...